Leonteq Securities AG’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-27,999
Closed -$154K 1487
2025
Q4
$154K Hold
27,999
﹤0.01% 718
2025
Q3
$91.6K Hold
27,999
﹤0.01% 768
2025
Q2
$64.7K Sell
27,999
-52,000
-65% -$113K ﹤0.01% 802
2025
Q1
$111K Hold
79,999
0.01% 677
2024
Q4
$138K Sell
79,999
-1
-0% -$2 0.01% 617
2024
Q3
$161K Buy
80,000
+27,000
+51% +$59.2K 0.01% 534
2024
Q2
$119K Buy
53,000
+25,000
+89% +$72.8K 0.01% 590
2024
Q1
$80.4K Buy
28,000
+20,000
+250% +$41.7K 0.01% 680
2023
Q4
$14.2K Buy
8,000
+3,000
+60% +$5.98K ﹤0.01% 973
2023
Q3
$15.8K Buy
+5,000
New +$9.34K ﹤0.01% 972

Other funds holding TSHA